ReP USP - Resultado da busca

Artigo de periodico
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup (2022)
Vergote, Ignace; Gonzalez-Martin, Antonio; Lorusso, Domenica; Gourley, Charlie; Mirza, Mansoor Raza; Kurtz, Jean-Emmanuel; Okamoto, Aikou; Moore, Kathleen; Kridelka, Frédéric; Reis, Francisco José Cândido dos
Source: The Lancet Oncology. Unidade: FMRP
Subjects: CARCINOMA, NEOPLASIAS OVARIANAS, QUIMIOTERAPIA, CIRURGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERGOTE, Ignace et al. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. The Lancet Oncology, v. 23, n. 8, p. e374-e384, 2022Tradução . . Disponível em: https://doi.org/10.1016/S1470-2045(22)00139-5. Acesso em: 17 nov. 2024.
APA
Vergote, I., Gonzalez-Martin, A., Lorusso, D., Gourley, C., Mirza, M. R., Kurtz, J. -E., et al. (2022). Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. The Lancet Oncology, 23( 8), e374-e384. doi:10.1016/S1470-2045(22)00139-5
NLM
Vergote I, Gonzalez-Martin A, Lorusso D, Gourley C, Mirza MR, Kurtz J-E, Okamoto A, Moore K, Kridelka F, Reis FJC dos. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup [Internet]. The Lancet Oncology. 2022 ; 23( 8): e374-e384.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/S1470-2045(22)00139-5
Vancouver
Vergote I, Gonzalez-Martin A, Lorusso D, Gourley C, Mirza MR, Kurtz J-E, Okamoto A, Moore K, Kridelka F, Reis FJC dos. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup [Internet]. The Lancet Oncology. 2022 ; 23( 8): e374-e384.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/S1470-2045(22)00139-5
Artigo de periodico
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers (2021)
Mattos-Arruda, Leticia De; Cortes, Javier; Blanco-Heredia, Juan; Tiezzi, Daniel Guimarães ; Villacampa, Guillermo; Gonçalves-Ribeiro, Samuel; Paré, Laia; Souza, Carla Anjos; Ortega, Vanesa; Sammut, Stephen-John
Source: NPJ Breast Cancer. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, EXPRESSÃO GÊNICA, TERAPIA BIOLÓGICA, HORMÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTOS-ARRUDA, Leticia De et al. The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers. NPJ Breast Cancer, v. 7, n. 73, p. 1-10, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41523-021-00282-0. Acesso em: 17 nov. 2024.
APA
Mattos-Arruda, L. D., Cortes, J., Blanco-Heredia, J., Tiezzi, D. G., Villacampa, G., Gonçalves-Ribeiro, S., et al. (2021). The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers. NPJ Breast Cancer, 7( 73), 1-10. doi:10.1038/s41523-021-00282-0
NLM
Mattos-Arruda LD, Cortes J, Blanco-Heredia J, Tiezzi DG, Villacampa G, Gonçalves-Ribeiro S, Paré L, Souza CA, Ortega V, Sammut S-J. The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers [Internet]. NPJ Breast Cancer. 2021 ; 7( 73): 1-10.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/s41523-021-00282-0
Vancouver
Mattos-Arruda LD, Cortes J, Blanco-Heredia J, Tiezzi DG, Villacampa G, Gonçalves-Ribeiro S, Paré L, Souza CA, Ortega V, Sammut S-J. The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers [Internet]. NPJ Breast Cancer. 2021 ; 7( 73): 1-10.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1038/s41523-021-00282-0
Artigo de periodico
Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients (2021)
Orlandini, Leonardo Fleury ; Pimentel, F. F.; Andrade, Jurandyr Moreira de ; Reis, Francisco José Candido dos; Mattos-Arruda, L. de; Tiezzi, Daniel Guimarães
Source: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, OBESIDADE, PROGNÓSTICO, SOBREVIVÊNCIA LIVRE DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORLANDINI, Leonardo Fleury et al. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients. Brazilian Journal of Medical and Biological Research, v. 54, n. 10, 2021Tradução . . Disponível em: https://doi.org/10.1590/1414-431X2021e11409. Acesso em: 17 nov. 2024.
APA
Orlandini, L. F., Pimentel, F. F., Andrade, J. M. de, Reis, F. J. C. dos, Mattos-Arruda, L. de, & Tiezzi, D. G. (2021). Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients. Brazilian Journal of Medical and Biological Research, 54( 10). doi:10.1590/1414-431X2021e11409
NLM
Orlandini LF, Pimentel FF, Andrade JM de, Reis FJC dos, Mattos-Arruda L de, Tiezzi DG. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2021 ; 54( 10):[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/1414-431X2021e11409
Vancouver
Orlandini LF, Pimentel FF, Andrade JM de, Reis FJC dos, Mattos-Arruda L de, Tiezzi DG. Obesity and high neutrophil-to-lymphocyte ratio are prognostic factors in non-metastatic breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2021 ; 54( 10):[citado 2024 nov. 17 ] Available from: https://doi.org/10.1590/1414-431X2021e11409
Artigo de periodico
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study (2020)
Swain, Sandra M.; Miles, David; Kim, Sung Bae; Im, Young-Hyuck; Im, Seock-Ah; Semiglazov, Vladimir; Ciruelos, Eva M.; Schneeweiss, Andreas; Loi, Sherene; Monturus, Estefanía; Clark, Emma; Knott, Adam; Restuccia, Eleonora; Benyunes, Mark C.; Cortés, Javier; Andrade, Jurandyr Moreira de
Source: The Lancet Oncology. Unidade: FMRP
Subjects: ANTICORPOS MONOCLONAIS, PROTOCOLOS CLÍNICOS, QUIMIOTERAPIA COMBINADA, ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, MÉTODO DUPLO-CEGO, METÁSTASE NEOPLÁSICA, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SWAIN, Sandra M. et al. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. The Lancet Oncology, v. 21, n. 4, p. 519-530, 2020Tradução . . Disponível em: https://doi.org/10.1016/S1470-2045(19)30863-0. Acesso em: 17 nov. 2024.
APA
Swain, S. M., Miles, D., Kim, S. B., Im, Y. -H., Im, S. -A., Semiglazov, V., et al. (2020). Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. The Lancet Oncology, 21( 4), 519-530. doi:10.1016/S1470-2045(19)30863-0
NLM
Swain SM, Miles D, Kim SB, Im Y-H, Im S-A, Semiglazov V, Ciruelos EM, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J, Andrade JM de. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study [Internet]. The Lancet Oncology. 2020 ; 21( 4): 519-530.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/S1470-2045(19)30863-0
Vancouver
Swain SM, Miles D, Kim SB, Im Y-H, Im S-A, Semiglazov V, Ciruelos EM, Schneeweiss A, Loi S, Monturus E, Clark E, Knott A, Restuccia E, Benyunes MC, Cortés J, Andrade JM de. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study [Internet]. The Lancet Oncology. 2020 ; 21( 4): 519-530.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/S1470-2045(19)30863-0
Trabalho de evento-resumo periodico
Impact of local recurrence on disease-specific survival in breast cancer patients who underwent breast-conserving surgery (2020)
Tiezzi, Daniel Guimarães ; Mattos, L. de; Orlandini, Leonardo Fleury ; Reis, Francisco José Candido dos ; Carrara, Helio Humberto Angotti ; Rueda, O. M.; Caldas, C.; Andrade, J. M. D.
Source: Annals of Oncology. Conference titles: European Society for Medical Oncology Congress - ESMO. Unidade: FMRP
Subjects: NEOPLASIAS MAMÁRIAS, CIRURGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TIEZZI, Daniel Guimarães et al. Impact of local recurrence on disease-specific survival in breast cancer patients who underwent breast-conserving surgery. Annals of Oncology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.annonc.2020.03.216. Acesso em: 17 nov. 2024. , 2020
APA
Tiezzi, D. G., Mattos, L. de, Orlandini, L. F., Reis, F. J. C. dos, Carrara, H. H. A., Rueda, O. M., et al. (2020). Impact of local recurrence on disease-specific survival in breast cancer patients who underwent breast-conserving surgery. Annals of Oncology. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.annonc.2020.03.216
NLM
Tiezzi DG, Mattos L de, Orlandini LF, Reis FJC dos, Carrara HHA, Rueda OM, Caldas C, Andrade JMD. Impact of local recurrence on disease-specific survival in breast cancer patients who underwent breast-conserving surgery [Internet]. Annals of Oncology. 2020 ; 31 S54.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.annonc.2020.03.216
Vancouver
Tiezzi DG, Mattos L de, Orlandini LF, Reis FJC dos, Carrara HHA, Rueda OM, Caldas C, Andrade JMD. Impact of local recurrence on disease-specific survival in breast cancer patients who underwent breast-conserving surgery [Internet]. Annals of Oncology. 2020 ; 31 S54.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.annonc.2020.03.216
Artigo de periodico
Sex hormones and processing of facial expressions of emotion: a systematic literature review (2018)
Osório, Flávia de Lima; Cassis, Juliana M. de Paula; Sousa, João P. Machado de; Poli Neto, Omero Benedicto; Martín-Santos, Rocio
Source: Frontiers in Psychology. Unidade: FMRP
Subjects: EMOÇÕES, ANTICONCEPÇÃO, PROGESTERONA, HORMÔNIOS SEXUAIS, TESTOSTERONA, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OSÓRIO, Flávia de Lima et al. Sex hormones and processing of facial expressions of emotion: a systematic literature review. Frontiers in Psychology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fpsyg.2018.00529. Acesso em: 17 nov. 2024.
APA
Osório, F. de L., Cassis, J. M. de P., Sousa, J. P. M. de, Poli Neto, O. B., & Martín-Santos, R. (2018). Sex hormones and processing of facial expressions of emotion: a systematic literature review. Frontiers in Psychology, 9. doi:10.3389/fpsyg.2018.00529
NLM
Osório F de L, Cassis JM de P, Sousa JPM de, Poli Neto OB, Martín-Santos R. Sex hormones and processing of facial expressions of emotion: a systematic literature review [Internet]. Frontiers in Psychology. 2018 ; 9[citado 2024 nov. 17 ] Available from: https://doi.org/10.3389/fpsyg.2018.00529
Vancouver
Osório F de L, Cassis JM de P, Sousa JPM de, Poli Neto OB, Martín-Santos R. Sex hormones and processing of facial expressions of emotion: a systematic literature review [Internet]. Frontiers in Psychology. 2018 ; 9[citado 2024 nov. 17 ] Available from: https://doi.org/10.3389/fpsyg.2018.00529
Artigo de periodico
Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies (2018)
Gielen, Marij; Hageman, Geja J.; Antoniou, Evangelia E.; Nordfjall, Katarina; Mangino, Massimo; Balasubramanyam, Muthuswamy; Meyer, Tim de; Hendricks, Audrey E.; Giltay, Erik J.; Hunt, Steven C.; Nettleton, Jennifer A.; Salpea, Klelia D.; Diaz, Vanessa A.; Farzaneh-Far, Ramin; Atzmon, Gil; Harris, Sarah E.; Hou, Lifang; Gilley, David; Hovatta, Iiris; Kark, Jeremy D.; Nassar, Hisham; Kurz, David J.; Mather, Karen A; Willeit, Peter; Zheng, Yun-Ling; Pavanello, Sofia; Demerath, Ellen W.; Rode, Line; Bunout, Daniel; Steptoe, Andrew; Boardman, Lisa; Marti, Amelia; Needham, Belinda; Zheng, Wei; Ramsey Goldman, Rosalind; Pellatt, Andrew J; Kaprio, Jaakko; Hofmann, Jonathan N.; Gieger, Christian; Paolisso, Giuseppe; Hjelmborg, Jacob B. H.; Mirabello, Lisa; Seeman, Teresa; Wong, Jason; van der Harst, Pim; Broer, Linda; Kronenberg, Florian; Kollerits, Barbara; Strandberg, Timo; Eisenberg, Dan T. A.; Duggan, Catherine; Verhoeven, Josine E.; Schaakxs, Roxanne; Zannolli, Raffaela; Reis, Rosana Maria dos; Charchar, Fadi J; Tomaszewski, Maciej; Mons, Ute; Demuth, Ilja; Iglesias Molli, Andrea Elena; Cheng, Guo; Krasnienkov, Dmytro; D'Antono, Bianca; Kasielski, Marek; McDonnell, Barry J.; Ebstein, Richard Paul; Sundquist, Kristina; Paré, Guillaume; Chong, Michael; Zeegers, Maurice P.
Source: The American Journal of Clinical Nutrition. Unidade: FMRP
Subjects: TELÔMERO, OBESIDADE, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIELEN, Marij et al. Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies. The American Journal of Clinical Nutrition, v. 108, p. 453–475, 2018Tradução . . Disponível em: https://doi.org/10.1093/ajcn/nqy107. Acesso em: 17 nov. 2024.
APA
Gielen, M., Hageman, G. J., Antoniou, E. E., Nordfjall, K., Mangino, M., Balasubramanyam, M., et al. (2018). Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies. The American Journal of Clinical Nutrition, 108, 453–475. doi:10.1093/ajcn/nqy107
NLM
Gielen M, Hageman GJ, Antoniou EE, Nordfjall K, Mangino M, Balasubramanyam M, Meyer T de, Hendricks AE, Giltay EJ, Hunt SC, Nettleton JA, Salpea KD, Diaz VA, Farzaneh-Far R, Atzmon G, Harris SE, Hou L, Gilley D, Hovatta I, Kark JD, Nassar H, Kurz DJ, Mather KA, Willeit P, Zheng Y-L, Pavanello S, Demerath EW, Rode L, Bunout D, Steptoe A, Boardman L, Marti A, Needham B, Zheng W, Ramsey Goldman R, Pellatt AJ, Kaprio J, Hofmann JN, Gieger C, Paolisso G, Hjelmborg JBH, Mirabello L, Seeman T, Wong J, van der Harst P, Broer L, Kronenberg F, Kollerits B, Strandberg T, Eisenberg DTA, Duggan C, Verhoeven JE, Schaakxs R, Zannolli R, Reis RM dos, Charchar FJ, Tomaszewski M, Mons U, Demuth I, Iglesias Molli AE, Cheng G, Krasnienkov D, D'Antono B, Kasielski M, McDonnell BJ, Ebstein RP, Sundquist K, Paré G, Chong M, Zeegers MP. Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies [Internet]. The American Journal of Clinical Nutrition. 2018 ; 108 453–475.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1093/ajcn/nqy107
Vancouver
Gielen M, Hageman GJ, Antoniou EE, Nordfjall K, Mangino M, Balasubramanyam M, Meyer T de, Hendricks AE, Giltay EJ, Hunt SC, Nettleton JA, Salpea KD, Diaz VA, Farzaneh-Far R, Atzmon G, Harris SE, Hou L, Gilley D, Hovatta I, Kark JD, Nassar H, Kurz DJ, Mather KA, Willeit P, Zheng Y-L, Pavanello S, Demerath EW, Rode L, Bunout D, Steptoe A, Boardman L, Marti A, Needham B, Zheng W, Ramsey Goldman R, Pellatt AJ, Kaprio J, Hofmann JN, Gieger C, Paolisso G, Hjelmborg JBH, Mirabello L, Seeman T, Wong J, van der Harst P, Broer L, Kronenberg F, Kollerits B, Strandberg T, Eisenberg DTA, Duggan C, Verhoeven JE, Schaakxs R, Zannolli R, Reis RM dos, Charchar FJ, Tomaszewski M, Mons U, Demuth I, Iglesias Molli AE, Cheng G, Krasnienkov D, D'Antono B, Kasielski M, McDonnell BJ, Ebstein RP, Sundquist K, Paré G, Chong M, Zeegers MP. Body mass index is negatively associated with telomere length: a collaborative cross-sectional meta-analysis of 87 observational studies [Internet]. The American Journal of Clinical Nutrition. 2018 ; 108 453–475.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1093/ajcn/nqy107
Artigo de periodico
Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse (2016)
Checa, Miguel Angel; Teixeira, Danielle M.; González-Comadran, Mireia; Nastri, Carolina Oliveira; Martins, Wellington de Paula
Source: Cochrane Database of Systematic Reviews. Unidade: FMRP
Subjects: INFERTILIDADE FEMININA, FERTILIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHECA, Miguel Angel et al. Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse. Cochrane Database of Systematic Reviews, v. 2016, n. 11, 2016Tradução . . Disponível em: https://doi.org/10.1002/14651858.CD012396. Acesso em: 17 nov. 2024.
APA
Checa, M. A., Teixeira, D. M., González-Comadran, M., Nastri, C. O., & Martins, W. de P. (2016). Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse. Cochrane Database of Systematic Reviews, 2016( 11). doi:10.1002/14651858.CD012396
NLM
Checa MA, Teixeira DM, González-Comadran M, Nastri CO, Martins W de P. Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse [Internet]. Cochrane Database of Systematic Reviews. 2016 ; 2016( 11):[citado 2024 nov. 17 ] Available from: https://doi.org/10.1002/14651858.CD012396
Vancouver
Checa MA, Teixeira DM, González-Comadran M, Nastri CO, Martins W de P. Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse [Internet]. Cochrane Database of Systematic Reviews. 2016 ; 2016( 11):[citado 2024 nov. 17 ] Available from: https://doi.org/10.1002/14651858.CD012396

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Indexado em

Non normalized affiliation

Countries of institutions of collaboration